BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29440643)

  • 1. Dissection and function of autoimmunity-associated TNFAIP3 (A20) gene enhancers in humanized mouse models.
    Sokhi UK; Liber MP; Frye L; Park S; Kang K; Pannellini T; Zhao B; Norinsky R; Ivashkiv LB; Gong S
    Nat Commun; 2018 Feb; 9(1):658. PubMed ID: 29440643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of A20 in autoimmune diseases.
    Zhang M; Peng LL; Wang Y; Wang JS; Liu J; Liu MM; Hu J; Song B; Yang HB
    Immunol Res; 2016 Apr; 64(2):337-44. PubMed ID: 26135958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNGR1-mediated deletion of A20/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology.
    Das T; Bergen IM; Koudstaal T; van Hulst JAC; van Loo G; Boonstra A; Vanwolleghem T; Leung PSC; Gershwin ME; Hendriks RW; Kool M
    J Autoimmun; 2019 Aug; 102():167-178. PubMed ID: 31151831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.
    Mele A; Cervantes JR; Chien V; Friedman D; Ferran C
    Adv Exp Med Biol; 2014; 809():163-83. PubMed ID: 25302371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TALEN-mediated enhancer knockout influences TNFAIP3 gene expression and mimics a molecular phenotype associated with systemic lupus erythematosus.
    Wang S; Wen F; Tessneer KL; Gaffney PM
    Genes Immun; 2016 Apr; 17(3):165-70. PubMed ID: 26821284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
    Das T; Chen Z; Hendriks RW; Kool M
    Front Immunol; 2018; 9():104. PubMed ID: 29515565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein citrullination and NET formation do not contribute to the pathology of A20/TNFAIP3 mutant mice.
    Van Damme KFA; Hertens P; Martens A; Gilis E; Priem D; Bruggeman I; Fossoul A; Declercq J; Aegerter H; Wullaert A; Hochepied T; Hoste E; Vande Walle L; Lamkanfi M; Savvides SN; Elewaut D; Lambrecht BN; van Loo G
    Sci Rep; 2023 Oct; 13(1):17992. PubMed ID: 37865713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease.
    Vereecke L; Beyaert R; van Loo G
    Biochem Soc Trans; 2011 Aug; 39(4):1086-91. PubMed ID: 21787353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A20 SNP rs77191406 may be related to secondary cancer for rheumatoid arthritis and systemic lupus erythematosus patients.
    Zhu L; Zhou L; Wang L; Li Z; Lu S; Yang L; Chen S; Li B; Wu X; Zhou Y; Li Y
    Asia Pac J Clin Oncol; 2016 Dec; 12(4):409-414. PubMed ID: 27435953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A20 at the Crossroads of Cell Death, Inflammation, and Autoimmunity.
    Martens A; van Loo G
    Cold Spring Harb Perspect Biol; 2020 Jan; 12(1):. PubMed ID: 31427375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Super-enhancers delineate disease-associated regulatory nodes in T cells.
    Vahedi G; Kanno Y; Furumoto Y; Jiang K; Parker SC; Erdos MR; Davis SR; Roychoudhuri R; Restifo NP; Gadina M; Tang Z; Ruan Y; Collins FS; Sartorelli V; O'Shea JJ
    Nature; 2015 Apr; 520(7548):558-62. PubMed ID: 25686607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomorphic A20 expression confers susceptibility to psoriasis.
    Aki A; Nagasaki M; Malynn BA; Ma A; Kagari T
    PLoS One; 2017; 12(6):e0180481. PubMed ID: 28658319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset autoimmune disease due to a heterozygous loss-of-function mutation in
    Duncan CJA; Dinnigan E; Theobald R; Grainger A; Skelton AJ; Hussain R; Willet JDP; Swan DJ; Coxhead J; Thomas MF; Thomas J; Zamvar V; Slatter MA; Cant AJ; Engelhardt KR; Hambleton S
    Ann Rheum Dis; 2018 May; 77(5):783-786. PubMed ID: 28659290
    [No Abstract]   [Full Text] [Related]  

  • 14. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity.
    Koumakis E; Giraud M; Dieudé P; Cohignac V; Cuomo G; Airò P; Hachulla E; Matucci-Cerinic M; Diot E; Caramaschi P; Mouthon L; Riccieri V; Cracowski JL; Tiev KP; Francès C; Amoura Z; Sibilia J; Cosnes A; Carpentier P; Valentini G; Manetti M; Guiducci S; Meyer O; Kahan A; Boileau C; Chiocchia G; Allanore Y
    Arthritis Rheum; 2012 Aug; 64(8):2746-52. PubMed ID: 22488580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Novel Mutation in
    Rossi MN; Federici S; Uva A; Passarelli C; Celani C; Caiello I; Matteo V; Petrocchi S; Mortari EP; De Benedetti F; Prencipe G; Insalaco A
    Front Immunol; 2022; 13():804401. PubMed ID: 35154120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A zebrafish functional genomics model to investigate the role of human A20 variants in vivo.
    Cultrone D; Zammit NW; Self E; Postert B; Han JZR; Bailey J; Warren J; Croucher DR; Kikuchi K; Bogdanovic O; Chtanova T; Hesselson D; Grey ST
    Sci Rep; 2020 Nov; 10(1):19085. PubMed ID: 33154446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of A20 in BM-MSCs regulates the Th17/Treg balance in Rheumatoid Arthritis.
    Feng Z; Zhai Y; Zheng Z; Yang L; Luo X; Dong X; Han Q; Jin J; Chen ZN; Zhu P
    Sci Rep; 2018 Jan; 8(1):427. PubMed ID: 29323140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three single nucleotide polymorphisms of TNFAIP3 gene increase the risk of rheumatoid arthritis.
    Shen N; Ruan Y; Lu Y; Jiang X; Sun H; Gao G; Nong L; Ren K
    Oncotarget; 2017 Mar; 8(13):20784-20793. PubMed ID: 28199970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis.
    De Wilde K; Martens A; Lambrecht S; Jacques P; Drennan MB; Debusschere K; Govindarajan S; Coudenys J; Verheugen E; Windels F; Catrysse L; Lories R; McGonagle D; Beyaert R; van Loo G; Elewaut D
    Ann Rheum Dis; 2017 Mar; 76(3):585-592. PubMed ID: 27551052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: Enhancers in Autoimmune Arthritis: Implications and Therapeutic Potential.
    Peeters JGC; Vastert SJ; van Wijk F; van Loosdregt J
    Arthritis Rheumatol; 2017 Oct; 69(10):1925-1936. PubMed ID: 28666076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.